Atlas Trials

Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate Cancer

Clinical trial NCT02339168 · COMPLETED

Trial details

NCT number
NCT02339168
Sponsor
University of California, Davis
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2016-06-22
Primary completion
2024-10-15
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.